Luinstra, M., Rutgers, W., van Laar, T., Grasmeijer, F., Begeman, A., Isufi, V., . . . Frijlink, H. W. (2019). Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson’s disease. Ther Adv Chronic Dis.
Chicago Stili AlıntıLuinstra, Marianne, et al. "Pharmacokinetics and Tolerability of Inhaled Levodopa From a New Dry-powder Inhaler in Patients With Parkinson’s Disease." Ther Adv Chronic Dis 2019.
MLA AlıntıLuinstra, Marianne, et al. "Pharmacokinetics and Tolerability of Inhaled Levodopa From a New Dry-powder Inhaler in Patients With Parkinson’s Disease." Ther Adv Chronic Dis 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..